ARCELIS
Dead / Cancelled — Cancelled — Section 8 (as of 13 May 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77174310
- Registration number
- 4841570
- Mark type
- Stylized text
- Filed
- 07 May 2007
- Published for opposition
- 12 Apr 2011
- Registered
- 27 Oct 2015
- Attorney of record
- Holly A. Coldiron
Goods and services
- Class 042 — Scientific and technological services: Research and development for others in the field of human diseases and vaccines, namely, research and development of cell preparations, cellular vaccines, and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy
Owner
- Argos Therapeutics, Inc., Durham, NC, US
- Argos Therapeutics, Inc., Durham, NC, US
- Argos Therapeutics, Inc., Durham, NC, US
Prosecution history
- 13 May 2022 — CANCELLED SEC. 8 (6-YR)
- 27 Oct 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Oct 2015 — REGISTERED-PRINCIPAL REGISTER
- 23 Sept 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Sept 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Sept 2015 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Sept 2015 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Aug 2015 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Mar 2015 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Mar 2015 — NON-FINAL ACTION E-MAILED
- 19 Mar 2015 — SU - NON-FINAL ACTION - WRITTEN
- 01 Mar 2015 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jan 2015 — USE AMENDMENT FILED
- 16 Jan 2015 — TEAS STATEMENT OF USE RECEIVED
- 10 Oct 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED